farmatic biotech energy ag
farmatic biot. energy ag english
farmatic biotech energy ag boosts revenues in first half of 2002
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
farmatic biotech energy ag boosts revenues in first half of 2002
Nortorf, August 30, 2002. farmatic biotech energy ag (SIN 605192) has posted
sales revenues of 16.4 million euros in the first six months of its fiscal year
2002 (prior year: 13.4 million euros). The Bio-Power Plant Technology segment
contributed 12.0 million euros (prior year: 11.6 million euros) to total sales.
The companys second segment, Sewage Treatment Technology, generated sales of 4.3
million euros (prior year: 1.7 million euros).
The sale of shares in operating companies is not planned until the fourth
quarter of 2002. The first two quarters were burdened by pre-production costs
resulting from the companys strong order position. farmatic will be constructing
over 20 bio-power plants in the coming months. At -5.8 million euros, operating
profits were in line with expectations. Due to its strong order backlog and the
steady increase in demand for bio-power plants and services in the field of
mechanical-biological waste treatment, the companys Management Board expect that
business will continue to make strong progress.
Information and explanations on this ad-hoc statement
Based in Nortorf, Germany, farmatic biotech energy ag is one of the leading
companies for the industrial conversion of biomass into biogas for the
production of regenerative en-ergy. In its Bio-Power Plant Technology division
farmatic is engaged in the develop-ment, planning and construction of mid-sized
and large industrially-operated biogas power plants. These power plants are
either operated by farmatic itself or in cooperation with other companies. The
companys Sewage Treatment Technology division comprises the development,
planning and construction of biological waste water purification plants.
farmatic has been listed in the Neuer Markt segment of the German stock ex-
change since April 9, 2001 (SIN 605192).
Please contact Ms. Margitta Kley (Corporate Communications) for all further
details.
Phone: +49 (4392) 9177-128, Fax: +49 (4392) 9177-297, E-mail: ir@farmatic.com
end of ad-hoc-announcement (c)DGAP 30.08.2002
——————————————————————————–
WKN: 605192 ; ISIN: DE0006051923; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart;
300730 Aug 02
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found